In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone diseaseThomas Lund,Michael Tveden Gundesen,Annette Juul Vangsted,Carsten Helleberg,Einar Haukås,Trine Silkjær,Jon Thor Asmussen,Elena Manuela Teodorescu,Bo Amdi Jensen,Tobias Schmidt Slørdahl,Hareth Nahi,Anders Waage,Niels Abildgaard,Fredrik SchjesvoldBlood Cancer Journal(2024)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要